Yissum's President and Chief Executive
Yaacov Michlin serves as Yissum's President and Chief Executive Officer since 2009. Mr. Michlin has been leading more than 200 licensing deals and the creation of more than 30 start up companies. Mr. Michlin also led Yissum to the signing of long term collaborations with Roche, P&G , Coca Cola and other leading companies and also led the creation and capital raising of Yissum's new holding company Integra that acts as VC to fund biotech projects of HU. Mr. Michlin currently serves as chairman and board member of few of Yissum leading spin-off companies in the biotech and agriculture fields. Before joining Yissum, Yaacov was involved in consulting to pharmaceutical, hi-tech and biomedical companies (including Teva, Bioline, CBI and Brainsway) in various technology commercialization deals, licensing agreements, capital raising, mergers and acquisitions and joint venture collaborations. He holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and an MBA, cum laude, from the Technion Israel Institute of Technology, Israel.